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We show that miR-1, a conserved muscle-specific
microRNA, regulates aspects of both pre- and post-
synaptic function at C. elegans neuromuscular junc-
tions. miR-1 regulates the expression level of two
nicotinic acetylcholine receptor (nAChR) subunits
(UNC-29 and UNC-63), thereby altering muscle sen-
sitivity to acetylcholine (ACh). miR-1 also regulates
the muscle transcription factor MEF-2, which results
in altered presynaptic ACh secretion, suggesting that
MEF-2 activity in muscles controls a retrograde sig-
nal. The effect of the MEF-2-dependent retrograde
signal on secretion is mediated by the synaptic ves-
icle protein RAB-3. Finally, acute activation of
levamisole-sensitive nAChRs stimulates MEF-2-de-
pendent transcriptional responses and induces the
MEF-2-dependent retrograde signal. We propose
that miR-1 refines synaptic function by coupling
changes in muscle activity to changes in presynaptic
function.
INTRODUCTION
Faithful synaptic transmission requires that neurotransmitter re-
lease is matched to postsynaptic receptor function. This coordi-
nation is achieved through bidirectional signaling between pre-
and postsynaptic cells. A variety of mechanisms are proposed
to mediate coupling of pre- and postsynaptic function including
signaling by retrogrademessengers and trans-synaptic adhesion
molecules (Davis and Bezprozvanny, 2001; Kalinovsky and
Scheiffele, 2004; Scheiffele, 2003). By bridging the pre- andpost-
synapse, these molecules are considered likely candidates for
coordinating synapse refinement. Many questions remain to be
answered about this process. What upstream signaling pathways
are directly involved in coupling changes across the synapse?What downstream molecular targets mediate the pre- and post-
synaptic changes? Here we provide evidence that a conserved
muscle microRNA, miR-1, is involved in this process.
MicroRNAs regulate several aspects of neuronal development
(Kosik, 2006). In C. elegans, left/right asymmetric cell fate of
chemosensory neurons during development is controlled by mi-
croRNAs (Johnston and Hobert, 2003), as is the switch to neuro-
nal-specific gene expression during vertebrate neurogenesis
(Cao et al., 2006). In zebrafish, a single microRNA is required
for development of the nervous system (Giraldez et al., 2005).
While microRNAs were originally identified based on their regu-
lation of developmental processes, it is becoming apparent
that microRNAs also regulate properties of mature tissues. For
example, in cultured rodent neurons, microRNAs have been im-
plicated in coupling the response to neurotrophins with changes
in the size of dendritic spines (Schratt et al., 2006).
The early lethality of genetic mutants in the microRNA biosyn-
thetic pathway and the limited availability of conditional knock-
outs of individual microRNAs have prevented detailed analysis
of postdevelopmental roles for microRNAs such as miR-1. The
sequence and muscle-specific expression of miR-1 are con-
served in all species examined (Nguyen and Frasch, 2006). Fly
and mouse miR-1 knockouts are lethal (Sokol and Ambros,
2005; Zhao et al., 2007), underscoring its importance as a devel-
opmental regulator. C. elegans mir-1 mutants are viable, allow-
ing the dissection of miR-1 function in adult animals. We show
that miR-1 regulates synaptic transmission at neuromuscular
junctions (NMJs), and that it does so by regulating nicotinic ace-
tylcholine receptors (nAChRs) and the generation of a retrograde
signal that modulates the function of presynaptic terminals.
RESULTS
The C. elegans genome contains a single miR-1 ortholog with
perfect sequence conservation (Lee and Ambros, 2001). To
analyze the expression of mir-1, we generated a transcriptional
reporter construct in which themir-1 promoter drives expression
of GFP. This construct expressed GFP in both pharyngeal andCell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc. 903
Figure 1. miR-1 Affects Muscle Sensitivity to ACh
(A) A transcriptional reporter containing a 3.7 kb mir-1 promoter driving expression of GFP showed expression in body-wall and pharyngeal muscles.
(B) Body-wall muscle expresses two classes of nAChR: the ACR-16/a7 homo-pentamers and the levamisole sensitive hetero-pentamer containing UNC-29. The
ACR-16 receptor is activated by ACh while the UNC-29 receptor is activated by both ACh and levamisole (Lev).
(C) The time course of levamisole (0.2 mM) induced paralysis of WT and mir-1(gk276) was compared.
(D and E) Levamisole (100 mM, 0.5 s) evoked currents in bodymuscles were compared inWT (n = 18), unc-29(x29) (n = 3), andmir-1(gk276) (n = 9). Averaged traces
(D) and peak amplitudes (E) are shown.
(F and G) Acetylcholine (500 mM, 0.5 s) evoked currents in body muscles were compared in unc-29 and mir-1 unc-29 mutants. Averaged traces (F) and peak
amplitudes (G) are shown. (*) indicates changes that are significantly different (p < 0.01, Mann-Whitney) from control strains.
The mean endogenous EPSC amplitudes (H) and cumulative probability distributions of endogenous EPSC amplitudes (I) and decay taus (J) for mir-1 and WT
controls are compared.904 Cell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc.
body muscles, with no apparent expression in other tissues, in-
cluding neurons (Figure 1A). Thus, miR-1 expression is restricted
tomuscles in flies, mice, and worms. Two independentmir-1 de-
letion mutants (gk276 and tm1635) were viable as homozygotes
and did not display any overt behavioral abnormalities. Muscle
cell numbers and morphology were superficially normal in both
mir-1 mutants (data not shown). These results suggest that
lack ofmiR-1 did not grossly altermuscle development inworms.
Decreased Muscle Responsiveness to Nicotinic
Agonists inmir-1 Mutants
Worm body muscle contracts in response to activation of
nAChRs. Body muscles express two classes of nAChRs (Rich-
mond and Jorgensen, 1999) (Figure 1B). Levamisole-sensitive
nAChRs (LevRs) are hetero-pentamers containing alternative
a subunits (UNC-38, UNC-63, and LEV-8) and non-a subunits
(UNC-29 and LEV-1) (Brown et al., 2006). Body muscles also
express ACR-16/a7 homo-pentamers, which are insensitive to
levamisole (Francis et al., 2005; Touroutine et al., 2005). To de-
termine if some aspect of muscle function was altered, we as-
sayed the sensitivity ofmir-1mutants to levamisole. Levamisole
binds to and activates LevRs, leading to muscle contraction
and subsequent paralysis. Homozygous mir-1(gk276) and
mir-1(tm1635)mutantswereboth resistant to theparalytic effects
of levamisole (Figure 1C; data not shown). Consistent with these
behavioral results, levamisole-evoked currents recorded from
body wall muscles were significantly reduced in both mir-1 mu-
tants (Figures 1D and 1E and data not shown). The function of
ACR-16 channels can be assayed by measuring ACh-evoked
currents in unc-29 mutants (Francis et al., 2005; Touroutine
et al., 2005). The ACh-evoked currents in unc-29 single mutants
and unc-29mir-1doublemutantswere indistinguishable (Figures
1F and 1G). These results suggest that the number or activity of
LevRs on the surface of body muscles was decreased in mir-1
mutants, whereas ACR-16 receptors were unaffected.
Agonist-evoked currents are likely to be mediated by both
synaptic and nonsynaptic nAChRs. To determine if miR-1 regu-
lates the function of synaptic receptors, we recorded excitatory
postsynaptic currents (EPSCs) produced by the endogenous ac-
tivity of motor neurons. We observed a 23% decrease in the am-
plitude of endogenous EPSCs in mir-1 mutants (Figures 1H and
1I, p = 0.002, Student’s t test), as would be predicted if loss of
miR-1 reduces the activity of synaptic nAChRs.
Approximately 80% of the excitatory postsynaptic current in
body muscles is carried by ACR-16/a7 homo-pentamers, with
LevRs mediating the remaining 20% (Francis et al., 2005; Tour-
outine et al., 2005). Consequently, the decreased endogenous
EPSC amplitudes observed in mir-1 mutants could result from
a change in either the LevRs, ACR-16 receptors, or both. To
distinguish between these possibilities, we recorded EPSCs
from double mutants lacking miR-1 and one of the two classes
of nAChRs. The amplitudes of endogenous EPSCs in acr-16;
mir-1 double mutants and in unc-29 mir-1 double mutants
were significantly lower than those observed in the correspond-
ing single mutants, acr-16 and unc-29, respectively (Figures S1and S2 available online). These results suggest that miR-1
regulates the activity of synaptic ACR-16 and LevRs.
Different classes of nAChRs can often be distinguished by
their kinetics. Consistent with this idea, we found that the decay
kinetics of endogenous EPSCs in unc-29 mutants were signifi-
cantly faster than those recorded from wild-type (WT) controls
(Figure S2). These results indicate that synaptic currents medi-
ated by ACR-16 receptors have faster decay kinetics than those
mediated by LevRs. Similarly, inmir-1mutants, the decay kinet-
ics of endogenous EPSCs were significantly faster than those
recorded from WT controls and were virtually identical to those
observed in unc-29mutants (Figures 1J, 1K, and S2). These data
are consistent with a miR-1-dependent change in the activity of
synaptic LevRs. Interestingly, EPSC decay time constants in
mir-1 unc-29 double mutants were faster than in unc-29 single
mutants (Figure S2), suggesting that the kinetics of ACR-16-me-
diated synaptic currents are also affected inmir-1. These results
suggest that miR-1 regulates sensitivity of bodymuscles to ACh.
miR-1 Regulates nAChR Subunit Abundance
The decreased function of LevRs in mir-1 mutants could be
caused by altered abundance of receptor subunits. Consistent
with this idea, we found predicted miR-1 binding sites in the
30UTRs of the unc-29 and unc-63 mRNAs (Figure 2A). These
putative miR-1 binding sites were conserved in the orthologous
genes in the nematodeC. briggsae (Figure S3). The bioinformatic
algorithm mirBase also identified unc-63 as a predicted miR-1
target (Griffiths-Jones et al., 2006). By contrast, miR-1 binding
sites were not found in the 30UTRs of mRNAs encoding other
muscle nicotinic receptor subunits, including UNC-38, LEV-8,
LEV-1, and ACR-16.
We next investigated whether miR-1 regulates unc-29 and
unc-63. First, we analyzed expression of endogenous subunits
by immunostaining (Figures 2B–2D) and immunoblotting (Fig-
ures 2E and 2F). In both assays, we observed increased abun-
dance of endogenous UNC-29 and UNC-63 subunits in mir-1
mutants, whereas the abundance of a control subunit (UNC-
38) was unaltered. To determine if regulation of UNC-29 abun-
dance was mediated by the predicted miR-1 binding sites in
the 30UTR, we made a reporter construct in which the unc-29
30UTR was appended to GFP. When this construct was ex-
pressed in body muscles, we observed increased GFP abun-
dance in mir-1 mutants compared to WT (Figures 2G and 2H).
By contrast, GFP abundance was unaltered in mir-1 mutants
for reporter constructs containing the unc-38 30UTR or a muta-
genized unc-29 30UTR inwhich nucleotides in the three predicted
miR-1 binding sites were scrambled (Figures 2G and 2H). These
results support the idea that the unc-29 and unc-63 mRNAs are
miR-1 targets, while the unc-38mRNA is not.
Increased UNC-29 and UNC-63 Expression Decreases
Muscle Sensitivity to Levamisole
Decreased LevR function in mir-1 mutants could be caused
by increased abundance of UNC-29 and UNC-63 or by misre-
gulation of other miR-1 targets. To distinguish between these(K) Average endogenous EPSCs are shown for WT (black), mir-1(red), and a scaled version of mir-1 (blue).
The error bars in (C), (E), (G), and (H) indicate standard error of the mean (SEM).Cell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc. 905
Figure 2. miR-1 Regulates nAChR Subunit Abundance
(A) Sequence alignment of miR-1 binding sites (predicted using the Miranda algorithm) in the unc-29 and unc-63 30UTRs (Enright et al., 2003).
(B–F) Abundance of endogenous UNC-29, UNC-38, and UNC-63 in WT (n = 6) and mir-1 mutants (n = 6) was compared by immunofluorescence (B–D) and
immunoblotting (E and F). Scale bar indicates 10 mm.
(G–H) GFP abundance in body muscles wasmeasured in transgenic animals expressing constructs containing either aWT (n = 6) or mutagenized (3xMut) unc-29
30UTR (n = 6) or the unc-38 30UTR (n = 6). In unc-29 (3xMut), the sequence of the three miR-1 binding sites was scrambled (detailed in the Experimental Proce-
dures). (*) indicates changes that are significantly different (p < 0.01, Mann-Whitney) from control strains.
The error bars in (F) and (H) indicate SEM.possibilities, we analyzed the effect of increasing expression of
these subunits in WT animals. unc-29 and unc-63 cDNAs were
fused to the unc-54 30UTR, which lacks predicted miR-1 binding
sites. When the UNC-29 and UNC-63 constructs were coex-
pressed in bodymuscles ofWT animals, we observed resistance
to the paralytic effects of levamisole (Figure 3A) and a significant
decrease in the amplitude of levamisole-evoked currents re-
corded from body muscles (Figures 3B and 3C). By contrast,
no change in levamisole sensitivity was observed when either
construct was expressed alone in WT animals, nor when both
constructs were coexpressed in mir-1 mutants (Figure 3A).
Thus the levamisole resistance phenotype of mir-1 mutants
can be explained by the coordinate upregulation of UNC-29
and UNC-63. Overexpression of UNC-29 and UNC-63 was not
sufficient to cause a change in either the amplitude or kinetics
of endogenous EPSCs (Figure S4), suggesting that other miR-1906 Cell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc.targets may contribute to these defects. These results are con-
sistent with prior studies showing that changes in subunit com-
position alter the kinetics, conductance, and agonist affinity of
mammalian nAChRs (Millar, 2003).
Synaptic Transmission Is Reduced inmir-1 Mutants
The decreased muscle responsiveness to ACh prompted us to
consider whether miR-1 regulates synaptic transmission at
NMJs. Steady-state acetylcholine (ACh) secretion in living
worms can be assayed by measuring resistance to the acetyl-
choline esterase inhibitor aldicarb. Aldicarb treatment causes
accumulation of ACh at NMJs, leading to acute paralysis. Muta-
tions that decrease ACh secretion confer resistance to aldicarb-
induced paralysis (Miller et al., 1996). We found that mir-1
mutants were resistant to aldicarb (Figure 4C), as would be pre-
dicted if ACh release had been decreased. To more directly
assay ACh release, we recorded EPSCs from body muscles. We
found that the EPSC amplitudes and the total synaptic charge
transfer evoked by a depolarizing stimulus were significantly de-
creased in mir-1 mutants (Figures 4A and 4B; Table S1).
In principle, altered EPSCs and aldicarb responses could arise
either from a change in presynaptic release of ACh or from the
decreased activity of muscle LevRs. We did several experiments
to distinguish between these possibilities. First, the reduction in
EPSC amplitude inmir-1mutants (55%) was significantly greater
than that observed in unc-29 mutants (20%) (Francis et al.,
2005). Second, to control for changes in muscle sensitivity, we
measured quantal content. Changes in muscle sensitivity to
ACh alters quantal size, i.e., charge transfer that occurs following
release of a single synaptic vesicle. The number of vesicles
released following a stimulus can be estimated by measuring
the quantal content, which measures the ratio of postsynaptic
charge transfer that occurs following a depolarizing stimulus to
that which occurs during an endogenous EPSC. We found that
quantal content was also significantly reduced in mir-1 mutants
Figure 3. Overexpression of UNC-29 and UNC-63 Decreases Sensi-
tivity to Levamisole
(A) The time course of levamisole (0.2 mM) induced paralysis was compared
for WT, mir-1(gk276), and transgenic animals overexpressing UNC-29 [unc-
29(xs)], UNC-63 [unc-63(xs)], or both [unc-29(xs);unc-63(xs)]. Data shown for
WT and mir-1(gk276) are taken from Figure 1C.
(B and C) Levamisole (100 mM, 0.5 s) evoked currents in body muscles were
compared in WT (n = 5) or transgenic animals overexpressing both unc-29
and unc-63 [unc-29(xs);unc-63(xs)] (n = 6). Averaged traces (B) and peak
amplitudes (C) are shown. (#) indicates changes that are significantly different
(p < 0.05, Mann-Whitney) from control strains. The error bars in (A) and (C)
indicate SEM.(Table S1). These results suggest that the decreased stimulus-
evoked EPSC observed in mir-1 mutants is unlikely to result
from a change in muscle sensitivity.
The pool of primed synaptic vesicles can be measured by
evoking fusion with hypertonic sucrose (Rosenmund and Ste-
vens, 1996). We found that the EPSC evoked by hypertonic su-
crose was not altered inmir-1mutants compared toWT controls
(Figures 4D and 4E), suggesting that the decreased ACh secre-
tion observed in mir-1 mutants was not caused by a change in
vesicle priming.
As an independent assay of presynaptic function, we also re-
corded endogenous EPSCs. The rate of endogenous EPSCs
was significantly reduced in mir-1 mutants (50% WT rate, p <
0.0001, Student’s t test) compared to WT controls (Figures
4G–4I). The decreased endogenous EPSC rate was not a sec-
ondary consequence of the decreased EPSC amplitude
(Figure 1H) because only a 19% change in EPSC rate would be
predicted to result from a 23% decrease in amplitude. These
results suggest that mir-1 mutants have a presynaptic defect
leading to decreased ACh secretion.
Synapse Density Is Not Altered inmir-1 Mutants
The secretion defects observed in mir-1 mutants might be
caused by a decrease in the number of cholinergic NMJs. To ad-
dress this possibility, we examined the localization of two active
zone proteins, SYD-2/a-Liprin (GFP-tagged), UNC-10/RIM1 (en-
dogenous protein visualized with anti-UNC-10 antibodies), and
a synaptic vesicle protein (SNB-1/Synaptobrevin, GFP-tagged)
(Koushika et al., 2001; Zhen and Jin, 1999). We found that all
three presynaptic proteins had similar distributions in WT and
mir-1 mutants. In particular, the densities of SYD-2 and SNB-1
puncta in WT and mir-1 mutants were indistinguishable
(Figure S5). We also examined the distribution of a postsynaptic
protein, GFP-tagged ACR-16, and found that puncta density
was not reduced in mir-1 mutants (WT: 3.5 ± 0.1 puncta/10
mm, mir-1: 3.6 ± 0.1 puncta/10 mm, p = 0.59, Student’s t test).
Consequently, loss of miR-1 did not grossly alter the distribution
of pre- and postsynaptic proteins, nor the apparent number of
cholinergic NMJs.
Interestingly, the fluorescence intensities of SYD-2 and SNB-1
were significantly altered in mir-1 mutants: SNB-1 fluorescence
decreased (20%, p < 0.001, Student’s t test), whereas SYD-2
fluorescence increased (39%, p < 0.0001, Student’s t test).
These changes in fluorescence are unlikely to be caused by
changes in transcription since opposite changes in fluorescence
were observed despite the fact that both transgenes utilized the
same promoter (unc-129). The altered abundance of SNB-1 and
SYD-2 provides further evidence that mir-1 mutants have
presynaptic defects.
MEF-2 Mediates the Presynaptic Function of miR-1
What miR-1 target mediates the presynaptic defects observed
inmir-1mutants? The rate of endogenous EPSCs was not signif-
icantly altered in transgenic animals driving overexpression of
UNC-29 and UNC-63 in body muscles (Figure S4), indicating
that the presynaptic defect was not caused by changes in the
abundance of nAChR subunits in muscles. LevRs are expressed
both in muscle and neurons (Brown et al., 2006); however,Cell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc. 907
unc-29 mutants have a normal rate of endogenous EPSCs
(WT [n = 9] 11.4 ± 2 Hz, 19.7 ± 2.5 pA; unc-29(x29) [n = 7] 13.3 ±
2.2 Hz, 19.8 ± 5 pA). Thus, the presynaptic effects of miR-1 are
unlikely to bemediated by altered function of presynaptic LevRs.
Since changes in UNC-29 and UNC-63 function cannot ac-
count for the observed decrease in ACh secretion, we searched
for other miR-1 targets that might mediate this change in secre-
tion. Members of theMef2 family of transcription factors were re-
cently shown to regulate formation of excitatory synapses in cul-
tured rodent neurons (Flavell et al., 2006; Shalizi et al., 2006). This
prompted us to investigate whether MEF-2might function down-
streamofmiR-1 in regulating presynaptic function. There is a sin-
gle mef-2 ortholog in C. elegans that is ubiquitously expressed,
and mutants lacking MEF-2 are viable (Dichoso et al., 2000).
We identified two miR-1 binding sites in the 30UTR of the
mef-2 mRNA, both of which were conserved in C. briggsae
(Figure S6). In addition, mef-2 was identified as a predicted
miR-1 target in a genomewide computational prediction of mi-
croRNA targets (Lall et al., 2006). The 30UTR of the mouse
Mef2a mRNA was previously shown to inhibit translation, and
we found that it also contains three putative miR-1 binding sites
(Figure S7) (Black et al., 1997).
Figure 4. Decreased Presynaptic ACh
Secretion in mir-1 Mutants
Stimulus-evoked responses were recorded from
adult body-wall muscles in 1 mM CaCl2, 4 mM
MgCl2. Average stimulus-evoked responses (A) and
EPSC amplitudes (B) are compared for WT (n = 18)
and mir-1(gk276) (n = 18) animals. For stimulus-
evoked responses here and in subsequent figures,
approximately 2 ms, encompassing the stimulus
artifact, were blanked for clarity. Traces containing
stimulus artifacts are presented in Figure S9.
(C) The time course of aldicarb (1 mM) induced pa-
ralysis was compared for WT andmir-1(gk276).
(D–F) Sucrose-evoked EPSCs were recorded from
WT (n = 6) and mir-1 (n = 6) mutants. Representa-
tive sucrose responses (D), mean sucrose-evoked
charge transfer (1 s period after the stimulus) (E),
and mean sucrose-evoked quanta (F) are com-
pared. Sucrose-evoked quanta were computed
by dividing the sucrose-evoked charge transfer
by the average endogenous EPSCcharge transfer.
(G–I) Endogenous EPSCs were recorded from WT
and mir-1 adult animals. Representative traces
(G), mean endogenous EPSC rates (H), and cumu-
lative probability distributions for the interevent
intervals (I) are shown. (**) indicates a significant
difference (p < 0.0001, Student’s t test) from WT.
The error bars in (B), (C), (E), (F), and (H) indicate
SEM.
These data suggest that the mef-2
might be regulated by miR-1. Consistent
with this idea, expression of a GFP re-
porter construct containing the mef-2
30UTR in body muscles was significantly
increased in mir-1 mutants (Figure S6)
whereas GFP levels were unaltered
when this construct was expressed in
motor neurons (WT: 78.7 ± 0.9 A.U.; mir-1: 83.0 ± 7.0 A.U., p =
0.58, Student’s t test). Mouse Mef2 promotes expression of
miR-1 (Rao et al., 2006; Zhao et al., 2005); however, we found
no evidence for MEF-2-dependent changes in the expression
of a miR-1 transcriptional reporter (data not shown).
To determine if MEF-2 mediates the presynaptic functions of
miR-1, we analyzed mir-1 mef-2 double mutants (Figure 5).
Single mutants lacking MEF-2 had a 26% decrease in stimu-
lus-evoked EPSC amplitude (p = 0.02, Student’s t test) (Figures
5A and 5B) and a normal rate of endogenous EPSCs (Figures 5C
and 5D). The effects of the mir-1 mutation on stimulus-evoked
EPSC amplitude and endogenous EPSC rate were eliminated
in mir-1 mef-2 double mutants, and in both cases the mir-1 mu-
tant defects were restored by transgenic expression of MEF-2 in
body muscles (Figures 5A–5G). By contrast, the mef-2 mutation
did not correct the decreased levamisole-evoked current in
mir-1mutants (Figure S8), nor did it correct the defect in endog-
enous EPSC decay rate (data not shown). However, the defect in
endogenous EPSC amplitude was corrected inmir-1 mef-2 dou-
ble mutants (Figure 5E). These results suggest that muscle
expression of MEF-2 mediates all of the presynaptic effects of
miR-1 but does not mediate many of its postsynaptic effects.908 Cell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc.
These results further suggest that miR-1 and MEF-2 act in body
muscles to control a retrograde signal that regulates presynaptic
ACh secretion.
RAB-3 Mediates the Presynaptic Function
of miR-1 and MEF-2
The presynaptic secretion defect observed inmir-1mutants was
associated with a dramatic increase in the synaptic abundance
of YFP-tagged RAB-3. The increased YFP::RAB-3 abundance
was eliminated inmir-1 mef-2 double mutants and was restored
by transgenes driving mef-2 expression in body muscles
(Figures 6A–6F). RAB-3 is a small GTPase that associates with
synaptic vesicles in a GTP-dependent manner (Sudhof, 2004).
Decreased secretion can result from either increased or de-
creased RAB-3 expression (Schluter et al., 2004; Thiagarajan
et al., 2004). This prompted us to test whether the decreased se-
cretion observed in mir-1 mutants was caused by a decrease in
RAB-3 activity. If this were the case, one would expect that the
secretion defects observed in mir-1 and rab-3 single mutants
would be very similar, and that these defects would not be addi-
tive inmir-1; rab-3 double mutants. Consistent with this idea, we
Figure 5. MEF-2 Mediates the Presynaptic
Effects of miR-1
(A and B) Stimulus-evoked responses were
recorded from WT (n = 18), mef-2(gv1) (n = 8),
mir-1(gk276) (n = 18),mir-1 mef-2 (n = 9), andmir-1
mef-2 double mutants carrying a transgene driving
mef-2 expression in body muscles (mef-2 muscle
rescue, n = 6). Averaged responses (A) and mean
EPSC amplitudes (B) are shown.
(C–G) Endogenous EPSCs were recorded from
WT (n = 18), mef-2(gv1) (n = 9), mir-1(gk276)
(n = 18), mir-1 mef-2 (n = 9), and mir-1 mef-2;
mef-2 muscle rescue (n = 6). The mean frequency
(D), amplitude (E), andcumulativeprobability distri-
butions of interevent intervals (F and G) are shown.
Values that differ significantly from WT controls
are indicated: (*) p < 0.01, (**) p < 0.001, (#)
p < 0.05, Student’s t test.
The error bars in (B), (D), and (E) indicate SEM.
found that stimulus-evoked EPSC ampli-
tudes (Figures 6G and 6H) and the rates
of endogenous EPSCs (Figures 6I and
6J) were indistinguishable in mir-1 and
rab-3 single mutants, and additive effects
were not observed in mir-1; rab-3 double
mutants (Figures 6G–6L). These results
support the idea that the presynaptic
defects observed in mir-1 mutants are




The transcriptional activity of mouse
Mef2 is regulated by neuronal activity
(Flavell et al., 2006; Shalizi et al., 2006).
If MEF-2 transcriptional activity were similarly activity depen-
dent, the miR-1/LevR/MEF-2 pathway described here could
provide a mechanism to couple changes in muscle activity to
changes in presynaptic properties. To test this idea, we devel-
oped assays for MEF-2-dependent transcriptional activity. We
identified several genes whose mRNA abundance is MEF-2 de-
pendent, using gene chip analysis (D.J.S., K.T.-P., and J.M.K.,
unpublished observations). We focused our analysis on themus-
cle-expressed gene frm-4 (Roy et al., 2002), whose expression
was decreased 2.8-fold inmef-2mutants relative to WT controls
(p < 0.001, moderated t-statistic). Although frm-4may not repre-
sent a direct transcriptional target ofMEF-2, the abundance of its
transcript provides a molecular assay for MEF-2 activity.
To determine if MEF-2 transcriptional activity is regulated by
LevRs, we analyzed the abundance of frm-4 transcripts following
a 1 hr application of levamisole. Levamisole treatment increased
frm-4 mRNA abundance in WT animals but had no effect in
unc-29 mutants (Figure 7A), demonstrating that the increased
frm-4 expression was not caused by a nonspecific effect of drug
treatment. By contrast, following levamisole treatment of mef-2
mutants, frm-4 expression was not increased but was insteadCell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc. 909
significantly decreased. These results suggest that activation of
LevRs induces the transcriptional activity of MEF-2, and likely
other transcription factors.
Levamisole Treatment Induces the MEF-2-Dependent
Increase in RAB-3
If increased muscle activity, caused by levamisole treatment,
induces the transcriptional activity of MEF-2, then we would
expect that levamisole treatment would also induce the MEF-
2-dependent retrograde signal. Consistent with this idea, we
Figure 6. RAB-3 Is the Presynaptic Effector of the MEF-2-
Dependent Retrograde Message
(A–E) YFP-tagged RAB-3 (YFP::RAB-3) was expressed in the choliner-
gic DA motor neurons (using the unc-129 promoter) in the indicated
genotypes. Scale bars indicate 10 mm.
(F) RAB-3 punctal fluorescence was compared in WT (n = 50), mef-
2(gv1) (n = 65), mir-1(gk276) (n = 51), mir-1 mef-2 (n = 34), and mir-1
mef-2 double mutants with mef-2 muscle rescue (n = 29). Values
that differ significantly from WT controls are indicated: (*) p < 0.01,
(**) p < 0.001, Student’s t test.
(G and H) Stimulus-evoked responses were recorded from WT
(n = 18), mir-1(gk276) (n = 18), rab-3(js49) (n = 8), and mir-1; rab-3
(n = 6). Averaged responses (G) and EPSC amplitudes (H) are shown.
(I–L) Endogenous EPSCswere recorded fromWT (n=18),mir-1(gk276)
(n = 18), rab-3(js49) (n = 8), and mir-1; rab-3 (n = 6). Representative
traces (I), endogenous EPSC frequencies (J), amplitudes (K), and cu-
mulative probability distributions (L) of interevent intervals are shown
for the indicated genotypes. Values that differ significantly from
WT controls are indicated: (*) p < 0.01, (**) p < 0.001, Mann-Whitney.
The error bars in (F), (J), (H), and (K) indicate SEM.
found that the presynaptic abundance of YFP::RAB-3
was significantly increased following treatment with leva-
misole (Figures 7B, 7C, and 7J). We did several controls
to determine if this effect was specific for activation of
LevRs. First, treatment with nicotine, which activates
ACR-16 receptors (Francis et al., 2005), did not alter pre-
synaptic RAB-3 fluorescence (Figures 7P and 7Q). Sec-
ond, the levamisole effect was dependent upon the
activity of endogenous LevRs, as levamisole treatment
of unc-29 mutants did not alter RAB-3 fluorescence
(Figures 7D, 7E, and 7J). Third, this effect also required
MEF-2 activity in muscles since levamisole treatment of
mef-2mutants also failed to alter RAB-3 levels, but trans-
genes driving MEF-2 expression in body muscles re-
stored levamisole-induced increases in RAB-3 (Figures
7F–7J). Thus, acute activation of LevRs induces both
MEF-2 transcriptional activity and the retrograde mes-
sage, whereas acute activation of ACR-16 receptors
(with nicotine) did not.
If LevR activity is required to induce the retrograde sig-
nal, we would also expect that mutations inactivating
these receptors would block the presynaptic effects of
miR-1. Consistent with this idea, the effect of the mir-1
mutation on presynaptic RAB-3 levels was eliminated in
mir-1 unc-29 double mutants (Figures 7K–7O). These re-
sults demonstrate that the activity of LevRs plays a pivotal
role in regulating the activity of the retrograde message,
mediating both acute induction following levamisole treatment
and chronic induction in mir-1 mutants.
DISCUSSION
We show that the conserved microRNAmiR-1 acts in C. elegans
body muscle where it regulates both the sensitivity of muscle to
ACh and the amount of ACh released from presynaptic neurons,
via a retrograde messenger. miR-1 adjusts muscle sensitivity by
directly regulating mRNAs encoding two subunits of the LevR910 Cell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc.
(UNC-29andUNC-63),whereasmiR-1adjustspresynaptic prop-
erties by regulating the mRNA encoding the transcription factor
MEF-2. Acute activation of the LevR induces MEF-2-dependent
transcription and the production of a MEF-2-dependent retro-
grade message. These results suggest that miR-1, LevRs, and
MEF-2define a nicotinic signaling pathway that couples postsyn-
aptic activity with changes in presynaptic properties (Figure 7R).
A New Function for miR-1
Fly and mouse miR-1 knockouts suffer early lethality due to de-
fects in muscle proliferation (Sokol and Ambros, 2005; Zhao
Figure 7. Acute Activation of LevRs Initiates
MEF-2-Dependent Changes in Transcription
and a Retrograde Change in YFP::RAB-3
After 1 hr, Levamisole (200 mM) and mock-treated an-
imals were subjected to RNA extraction or imaging.
(A) Expression of frm-4 was measured by qPCR (n = 6
for WT and mef-2; n = 3 for unc-29). Values that differ
significantly from controls are indicated: (#) p < 0.05,
(*) p < 0.01, Mann-Whitney.
(B–I) YFP::RAB-3 in the DA neurons is shown for the in-
dicated genotypes. Scale bars indicate 10 mm.
(J) Average RAB-3 punctal fluorescence was com-
pared in WT (n = 25 mock, n = 18 lev.), unc-29(x29)
(n = 16 mock, n = 18 lev.), mef-2(gv1) (n = 20 mock,
n = 16 lev.), and mef-2 muscle rescue (n = 12 mock,
n = 17 lev.).
(K–O) unc-29mutations suppress the accumulation of
YFP::RAB-3 in mir-1 mutants. YFP::RAB-3 punctal
fluorescence is shown in the indicated genotypes.
(O) Average RAB-3 punctal fluorescence was com-
pared in WT, unc-29(x29), mir-1(gk276), and mir-1
unc-29 double mutants (n = 30 WT, n = 26 mir-1, n =
31 unc-29, n = 35mir-1 unc-29). Values that differ sig-
nificantly fromWT controls are indicated: (**) p < 0.001,
Student’s t test.
(P–Q) Nicotine treatment did not alter RAB-3 fluores-
cence in WT. (Q) RAB-3 punctal fluorescence was
compared in nicotine-treated and control animals
(n = 33 mock, n = 33 nic.).
(R) A model for miR-1 regulation of the MEF-2-depen-
dent retrograde signal. miR-1 regulates muscle sensi-
tivity to ACh by regulating the LevR and the magnitude
of presynaptic release by regulating the activity of
MEF-2. We suggest that misregulation of MEF-2 either
initiates or modulates a retrograde signal that inhibits
ACh release, most likely by decreasing the activity of
RAB-3. Our data are consistent with miR-1/UNC-29/
MEF-2 acting as part of a nicotinic signal transduction
pathway to couple muscle activity to the generation
of a retrograde signal that inhibits neurotransmitter
release.
The error bars in (A), (J), (O), and (Q) indicate SEM.
et al., 2007)whereasC.elegansmir-1mutants
are viable, and muscle develops normally.
There are several potential explanations for
this discrepancy. First, worm muscle precur-
sors do not undergo extensive proliferation
prior to myogenic differentiation; conse-
quently, the proliferative defects observed in
mouse and fly would not be expected to occur in wormmir-1mu-
tants.Second,muscledifferentiation in thewormdiffers fromother
metazoans in several ways.Wormbodymuscle precursors do not
undergo cell fusions, instead forming mature mononucleate mus-
cle cells. Third, several genes that are critical for normalmyogenic
development in other organisms (e.g., MEF-2 and MyoD) play no
apparent role in the worm (Chen et al., 1992; Dichoso et al.,
2000). These differences may explain why muscle development
occurs relatively normally inmir-1mutants.
In general, microRNAs have been described to regulate early
developmental processes. Given that muscles develop normallyCell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc. 911
in mir-1 mutants, we were able to identify novel functions for
miR-1 in the regulation of mature neuromuscular synapses.
Based on our results, we speculate that some microRNAs (like
miR-1) will regulate both early developmental processes as
well as the mature function of cells after development is com-
pleted. Consistent with a postdevelopmental function else-
where, miR-1 expression persists through adulthood in both fly
and mouse (Nguyen and Frasch, 2006).
microRNA Regulation of Subunit Diversity
in Heteromultimeric Receptors
Transcriptional regulation is thought to underlie changes in sub-
unit composition of heteromultimeric receptors. For example, in
vertebrates, nAChRs undergo a developmentally programmed
switch from the g to 3 subunits that is mediated by changes in
transcription of these genes (Gu and Hall, 1988; Missias et al.,
1996).
We propose that miR-1 provides an alternative posttrans-
criptional mechanism to regulate the subunit composition of
nAChRs. In mir-1 mutants, the abundance of targeted subunits
(UNC-29 and UNC-63) was increased and this was accompa-
nied by decreased muscle sensitivity to ACh. These changes in
muscle sensitivity are mediated in part by altered composition
of LevRs; however, other aspects of the postsynaptic phenotype
(e.g., the change in endogenous EPSC amplitude and kinetics)
are mediated by other miR-1 targets (e.g., MEF-2).
The precise mechanism by which LevR function is altered by
miR-1 remains unclear. These effects could arise from changes
in several aspects of receptor biogenesis and function, including
association with accessory subunits, assembly in the ER, traf-
ficking to the cell surface, or function of mature receptors on
the muscle surface. In principle, any of these receptor properties
could be modified by altered subunit composition.
Based on our results, we speculate that microRNAs may be
utilized to regulate other heteromultimeric receptor complexes
in an analogous manner. Subunit composition is known to regu-
late the signaling properties of many classes of receptors, e.g.,
growth factor receptors and cytokine receptors. Regulation by
microRNAs could provide a novel mechanism to rapidly alter
the composition and signaling properties of these receptors.
MEF-2 Mediates the Generation of a Retrograde
Synaptic Signal
Retrograde signaling has been proposed as a mechanism to ad-
just presynaptic release to match postsynaptic excitability dur-
ing development and ongoing synaptic activity. This phenome-
non has been extensively studied at the Drosophila NMJ where
a variety of postsynaptic disruptions each produce a retrograde
signal to increase neurotransmitter release (Davis and Bezproz-
vanny, 2001). In C. elegans, genetic data suggest the presence
of a retrograde message at synapses; however thus far the na-
ture of this message remains unknown (Doi and Iwasaki, 2002).
We show here that MEF-2 activity in body muscles induces a
retrograde signal that inhibits presynaptic release of ACh.
One puzzling aspect of our results is the phenotype of mef-2
single mutants. Since mef-2 mutations eliminate the retrograde
signal, one might expect that mef-2 mutants would have in-
creased ACh release; however, we observed decreased ACh912 Cell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc.secretion in mef-2 single mutants. Several mechanisms could
explain this discrepancy. First, the decreased ACh release could
be caused byMEF-2 functions unrelated to retrograde signaling.
Second, MEF-2 and the retrograde signal may not be active un-
der normal growth conditions. It seems likely that a homeostatic
pathway would only be induced following periods of unusually
high activity and consequently may be inactive under normal
growth conditions. Third, in the absence of an inducing signal,
Mef2 actively represses expression of some target genes (Shalizi
and Bonni, 2005; van der Linden et al., 2007). Thus, someMEF-2
targets will be derepressed in mef-2 mutants. Consequently,
mef-2 loss-of-function mutations may result in a weak induction
of the retrograde signal. Consistent with this idea, we observed
decreased ACh secretion and increased RAB-3 fluorescence
in mef-2 mutants, both of which suggest an increase in retro-
grade signaling. Further experiments are required to distinguish
between these possibilities.
Mammalian Mef2 proteins were previously implicated in
synapse formation. RNAi-mediated knockdown of rat Mef2A in-
creased the number of excitatory synapses formed onto cere-
bellar and hippocampal neurons (Flavell et al., 2006; Shalizi
et al., 2006). These results were interpreted as Mef2-mediated
regulation of either synapse formation or stability. Thus, in both
worm and mammalian studies, postsynaptic Mef2 regulates
aspects of synapse development or function.
Although the mechanisms leading to Mef2-dependent
changes in synapse formation in rat neurons have not been de-
fined, it seems possible that retrograde regulation of presynaptic
function may be involved in this process. Synapse refinement
during development often involves competition among synaptic
inputs, whereby weaker inputs are eliminated (Katz and Shatz,
1996; Sanes and Lichtman, 2001). We speculate that Mef2
effects on synapse formation in hippocampal neurons may be
mediated by retrograde inhibition of synaptic inputs, leading to
their elimination.
RAB-3 as an Effector of Retrograde Signaling
Although we have not identified the MEF-2-regulated retrograde
messenger, our results suggest that RAB-3 is the downstream
target of this activity. Presynaptic RAB-3 levels were increased
when retrograde signaling was induced (i.e., in mir-1 mutants
or following levamisole treatment), and these effects were de-
pendent onMEF-2 activity in muscles. Moreover, the ACh secre-
tion defects caused bymir-1 and rab-3mutations were strikingly
similar, and additive defects were not observed in double mu-
tants. Together these results strongly support the idea that the
miR-1/MEF-2-regulated retrograde messenger acts via changes
in presynaptic RAB-3 activity.
What is the mechanism underlying the secretion defects in
mir-1 mutants? Genetic studies in mice suggest that Rab3 pro-
teins act at a late stage in the synaptic vesicle cycle, after dock-
ing and priming, to promote calcium-evoked fusion (Schluter
et al., 2004). Our analysis of mir-1 mutants is entirely consistent
with this phenotype. We observed decreased stimulus-evoked
release and a decreased rate of endogenous EPSCs, whereas
there was no change in vesicle priming nor in the number of
primed vesicles available for release. Together these results
suggest that vesicle release probability was reduced in mir-1
mutants, as previously proposed for mice lacking Rab3 function
(Schluter et al., 2004). Decreased vesicular release probability
could be caused by decreased calcium influx or by decreased
calcium sensitivity of release. Given the strong conservation of
RAB-3 and MEF-2 function, it seems likely that Rab3 may also
be a presynaptic effector responsible for retrograde signaling
by Mef2 in mammalian neurons, and perhaps for other retro-
grade messengers.
Regulation of Retrograde Signaling by Muscle Activity
Several results suggest that the LevR/MEF-2 retrograde signal is
induced by muscle activity. For example, activation of muscle
LevRs induces MEF-2 transcriptional activity and the MEF-2-
mediated retrograde alteration of presynaptic RAB-3. By con-
trast, activation of muscle ACR-16 receptors with nicotine did
not induce the retrograde alteration of RAB-3. Thus, LevRs are
selectively coupled to MEF-2 function, providing a mechanism
to couplemuscle depolarization to the generation of a retrograde
message.
What confers activity dependence on the retrograde mes-
sage? Dephosphorylation of Mef2 induces its transcriptional ac-
tivity, and this dephosphorylation is often mediated by the cal-
cium-activated phosphatase calcineurin (Flavell et al., 2006;
Shalizi et al., 2006; Shalizi and Bonni, 2005). The calcium depen-
dence of MEF-2 activity could account for the activity depen-
dence of the retrograde message. Consistent with this idea,
LevRs isolated from worm extracts copurify with the C. elegans
ortholog of calcineurin, TAX-6 (Gottschalk et al., 2005). Roughly
50% of the current produced by muscle LevRs is mediated by
calcium (Richmond and Jorgensen, 1999). We propose that
association of calcineurin with LevRs provides a mechanism to
selectively couple activation of LevRs to induction of MEF-2
transcriptional activity and retrograde signaling.
Feedback inhibition by homeostatic plasticity is thought to
provide a mechanism to maintain consistent synaptic function
in the face of fluctuations in activity (Davis and Bezprozvanny,
2001; Turrigiano and Nelson, 2004). We propose that LevR/
MEF-2 retrograde signal identified here is an example of such
a homeostatic pathway. In this scenario (Figure 7R), during pe-
riods of increased activity, synaptic currents through the LevR
would activate MEF-2, which in turn would initiate a retrograde
message culminating in inactivation of RAB-3 and decreased
ACh secretion. Thus, this pathway provides a mechanism to
couple muscle depolarization to homeostatic inhibition of excit-
atory input.
We also show that miR-1 regulates multiple aspects of retro-
grade signaling. The subunit composition and function of LevRs
and the expression of MEF-2 are regulated by miR-1, all of
which would regulate induction of the retrograde signal. Consis-
tent with these regulatory effects, retrograde signaling was con-
stitutively active in mir-1 mutants. These results suggest that
miR-1 regulates the gain of this homeostatic signal. When
miR-1 activity is high, the threshold for inducing the retrograde
signal would be shifted to higher levels of muscle activity,
whereas the converse would be true when miR-1 activity is
low. Further experiments are required to determine which spe-
cific physiological conditions, or when during development,
miR-1 levels or activity are altered. Our results suggest thatmiR-1 provides a potential mechanism to adjust the intensity
of retrograde signaling.
EXPERIMENTAL PROCEDURES
Detailed descriptions of all methods are provided in the Supplemental Data
available online.
Strains were maintained at 20C on lawns of OP50 (for imaging and beh-
avior) or HB101 (for electrophysiology). A complete list of strains utilized is
provided in the Supplemental Experimental Procedures.
Western Blots and Immunofluorescence
Membranes were isolated from worm extracts by ultracentrifugation, solubl-
ized in sample buffer, and immunoblotted as described previously (Dreier
et al., 2005). Custom polyclonal antibodies were raised against recombinant
UNC-29, UNC-63, and UNC-38 GST-fusion proteins. Commercial anti-GFP
antibody (Clontech) was utilized. For whole-mount immunostaining, worms
were fixed with Bouin’s and processed as described previously (McEwen
et al., 2006).
Plasmids
All expression vectors are based on the pPD49.26 backbone (A. Fire). Stan-
dard methods were utilized to construct all plasmids. Full details will be pro-
vided upon request. A 2.4 kb myo-3 promoter was used for expression in
body muscles. nAChR and mef-2 cDNAs were isolated by RT-PCR. For
30UTR reporter constructs, a myristoylated GFP was cloned into pPD49.26
followed by 30UTR sequences derived from unc-29 (KP#1299), unc-38
(KP#1355), ormef-2 (KP#1394). pJK129 contains GFP fused to a mutagenized
unc-29 30UTR, in which the nucleotide sequences of the three miR-1 binding
sites were randomized.
Drug Treatment Assays
Young adult worms were transferred to plates containing 200 mM levamisole
and assayed for paralysis as described previously (Nurrish et al., 1999). For im-
aging and real-time PCR experiments, late L4wormswere transferred tomock
treatment plates or plates containing 200 mM levamisole or 30 mM nicotine.
After 1 hr, RNA was harvested or worms were immobilized for imaging.
Electrophysiology
Electrophysiology was done on dissected C. elegans as previously described
(Richmond and Jorgensen, 1999). All recording conditions, data acquisition,
and analysis were as described (McEwen et al., 2006). Data analysis was
carried out in Igor Pro using custom written software. Stimulus artifacts for
stimulus-evoked responses were removed for clarity. The Supplemental Data
contains a detailed description of our conditions and analysis.
Microscopy
Quantitative wide-field fluorescencemicroscopy was performed using custom
software as described previously (Dittman and Kaplan, 2006).
Real-Time PCR
Total RNA was extracted from synchronized L4 worms and reverse tran-
scribed (RetroScript, Ambion), according to the manufacturer’s suggestions.
Quantitative Real-Time PCR (qPCR) reactions were performed using SYBR
Green Supermix (BioRad) using a BioRad iCycler IQ. Relative abundance of
frm-4 and rpl-32 mRNAs was determined using gene-specific primers
(sequences provided upon request).
SUPPLEMENTAL DATA
Supplemental Data include Experimental Procedures, nine figures, and one
table and can be found with this article online at http://www.cell.com/cgi/
content/full/133/5/903/DC1/.Cell 133, 903–915, May 30, 2008 ª2008 Elsevier Inc. 913
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